Cardiovascular Diseases, Hypertension
Conditions
Keywords
Racial disparities, Digital technology, Hypertension
Brief summary
The coronavirus disease 2019 (COVID-19) pandemic has uprooted conventional health care delivery for routine ambulatory care, requiring health systems to rapidly adopt telemedicine capabilities. The digital divide, has been well documented with lower rates of technology and broadband adoption among racial/ethnic minorities. Additionally, Black patients suffer a disproportionate burden of hypertension and cardiovascular disease. This study will implement a text-based home hypertension monitoring program among Black Medicaid patients with hypertension and cardiovascular disease (CVD) and compare its uptake to the currently available blood pressure monitoring program using the patient portal that is integrated into the electronic health record (EHR).
Interventions
Patients will be asked to text their BP. They will receive an automated response to their texts.
Patients will be asked to upload their BP to the online patient portal. They will receive information on how to sign up and use the patient portal. Patients can upload their BP readings daily or at the end of the study period.
Sponsors
Study design
Eligibility
Inclusion criteria
* Self-identified Black race * Medicaid or Medicare insurance * Hypertension * Cardiovascular disease or presence of at least 1 cardiovascular risk factor * Seen for in-person consultation at the Heart and Vascular clinic at the Hospital of the University of Pennsylvania
Exclusion criteria
* Does not speak English * Already owns a BP cuff * Does not have internet access or a phone 15 with texting capabilities
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of BP measurements reported | 14 days | Number of BP results reported over the study period |
| Proportion of patients submitting 1 or more BP measurement | 14 days | Proportion of patients per study arm reporting at least one BP measurement |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient satisfaction | Within 2 weeks of end of study period | Patients will be asked to complete a survey about ease of use and likelihood of recommending the intervention |
Countries
United States